Mandamus Cannot Compel an Inmate’s Preferred MAT Medication Absent a Legislatively Created Duty (and Where an Adeate Remedy Exists)

I. Introduction

In State ex rel. Sandy v. Spatny, Slip Opinion No. 2026-Ohio-1176 (Apr. 3, 2026), the Supreme Court of Ohio denied a pro se inmate’s request for a writ of mandamus that would have compelled the warden of Grafton Correctional Institution to provide medication-assisted treatment (“MAT”) in the form of buprenorphine (Suboxone) or methadone. The relator, Joseph Sandy, argued that a common pleas court order required his placement in DRC’s opioid-treatment track (the “OTP,” governed by DRC protocol No. K-12). The respondent, Warden Jerry Spatny, countered that Sandy had been clinically assessed and offered MAT deemed clinically appropriate (naltrexone under DRC protocol No. K-10), which Sandy refused, and that Sandy lacked a clear legal right to the specific medications he demanded.

The case presented two central issues: (1) whether mandamus can be used to force prison officials to provide a particular form of addiction medication as a matter of “clear legal duty,” and (2) whether mandamus is available when the relator has an adequate remedy in the ordinary course of law—here, a motion to enforce the underlying trial-court entry.

II. Summary of the Opinion

The court held that Sandy failed to prove by clear and convincing evidence that he had a clear legal right to receive the MAT medication of his choice (Suboxone or methadone) or that the warden had a clear legal duty to provide it. The record showed that DRC staff screened Sandy for MAT, clinically recommended naltrexone based on protocols and assessment, and that Sandy declined the recommended treatment. The court also found that mandamus was independently barred because Sandy had an adequate remedy in the ordinary course of law: he could file a motion to enforce the trial court’s amended entry (the July 31, 2024 “K12” entry).

Additionally, the court declined to strike Sandy’s evidentiary submission and merit brief despite missing signatures, concluding the omissions were likely oversights and did not appear intended to defeat Civ.R. 11’s purpose.

III. Analysis

A. Precedents Cited

1. Civ.R. 11 and signature defects: State ex rel. Slager v. Trelka

The court relied on State ex rel. Slager v. Trelka, 2024-Ohio-5125, ¶ 8, to frame the governing rule: S.Ct.Prac.R. 3.08 and Civ.R. 11 require an unrepresented litigant to sign filed documents, and an unsigned filing may be stricken as “sham and false” if the lack of signature is intended to defeat the rule’s purpose. Applying that standard, the court treated Sandy’s omissions as non-fraudulent procedural defects—especially in light of his notarized affidavit—and exercised discretion to deny the motion to strike.

The significance is practical: even in extraordinary-writ cases (where strict compliance is often demanded), the court signaled that not every pro se filing defect will be fatal; the key inquiry is whether the defect undermines Civ.R. 11’s certification function or prejudices the opposing party.

2. The mandamus elements: State ex rel. Maras v. LaRose and State ex rel. Taylor v. Glasser

The court applied the canonical mandamus test from State ex rel. Maras v. LaRose, 2022-Ohio-866, ¶ 18: the relator must show (1) a clear legal right, (2) a clear legal duty, and (3) no adequate remedy in the ordinary course of law—each by clear and convincing evidence. It also invoked State ex rel. Taylor v. Glasser, 50 Ohio St.2d 165, 166 (1977), emphasizing mandamus as an “extraordinary remedy” issued with caution and only when the right is clear.

These precedents did more than supply boilerplate. They drove the court’s insistence that Sandy identify a genuinely enforceable legal duty (not merely a preference, a clinical disagreement, or a general order to participate in MAT), and they underpinned the court’s refusal to transform mandamus into a vehicle for second-guessing medical judgment within an established administrative program.

3. A mandamus duty must be legislatively created: State ex rel. Shie v. Adult Parole Auth., State ex rel. Tarrier v. Pub. Emps. Retirement Bd., and State ex rel. Perry Twp. Bd. of Trustees v. Husted

The central doctrinal move came from the court’s repeated admonition that “the creation of a duty enforceable in mandamus is the function of the legislature.” The court cited State ex rel. Shie v. Adult Parole Auth., 2022-Ohio-270, ¶ 11, and State ex rel. Tarrier v. Pub. Emps. Retirement Bd., 2021-Ohio-649, ¶ 18, quoting State ex rel. Perry Twp. Bd. of Trustees v. Husted, 2018-Ohio-3830, ¶ 13 (“this court cannot create a legal duty enforceable in mandamus; only the General Assembly has that authority”).

These cases supplied the governing limitation that defeated Sandy’s core theory: even if a trial court issues an entry about placement in a program, that does not necessarily create a “clear legal duty” enforceable by mandamus against executive officials. Unless a statute (or properly authorized administrative scheme with mandatory language implementing a statute) imposes a ministerial obligation, mandamus will not lie.

4. Pleading/record limits in original actions: State ex rel. Sands v. Court of Common Pleas Judge

When Sandy attempted in his merit brief to rely on the trial court’s July 31, 2024 amended entry (ordering placement in the “K12 MAT Program”), the court cited State ex rel. Sands v. Court of Common Pleas Judge, 2018-Ohio-4245, ¶ 11, for the principle that a relator’s failure to amend the complaint to include later developments can preclude reliance on them. The court also stressed an evidentiary shortcoming: Sandy did not place the amended entry into the record.

This precedent reinforced the court’s broader approach: mandamus is record-driven. The writ is not granted on unproven assertions or missing exhibits, especially where the requested relief would compel governmental action.

B. Legal Reasoning

1. No clear legal duty to provide the inmate’s medication of choice

The court separated two ideas that are often conflated in prison-treatment disputes:

  • Access to MAT as a program (i.e., screening, eligibility assessment, and an offered treatment plan under DRC protocols), and
  • Entitlement to a particular medication (e.g., buprenorphine or methadone rather than naltrexone).

On the evidence submitted, DRC did what the MAT framework contemplates: it screened Sandy “prompted by the court order,” evaluated suitability, and made a clinical recommendation—naltrexone. Sandy refused because he wanted OTP medication instead. The court treated that refusal as fatal to a mandamus claim that presupposed entitlement to a specific drug or track of treatment.

2. Trial-court entries did not supply an enforceable mandamus duty

As to the June 13, 2024 entry (the only order Sandy attached and emphasized in his complaint), the court read it narrowly: it ordered only placement in the MAT program and compliance with its requirements; it did not require a specific medication or require OTP/K-12 placement. Even assuming a trial-court entry could ever create a mandamus-enforceable duty (a proposition the court rejected in general terms), this entry lacked the specificity Sandy needed.

As to the July 31, 2024 amended entry, the court held Sandy could not rely on it because he did not amend his complaint and did not submit the entry as evidence. But the court went further: even if it were in the record, the entry would not establish a clear legal right to OTP placement. The court treated DRC protocols K-10 and K-12 as defining eligibility and clinical pathways. Sandy did not show that DRC lacked authority to adopt those protocols or that the protocols were unlawfully applied. In that posture, mandamus could not be used to override the clinical eligibility decision or to force OTP admission.

3. Adequate remedy at law independently barred the writ

The court held that Sandy had an adequate remedy in the ordinary course of law: a motion to enforce the trial court’s amended entry. This point is doctrinally decisive in mandamus. Even a strong showing on right/duty can fail if an adequate legal remedy exists. Here, because Sandy’s theory was fundamentally about compliance with a trial-court order, the enforcement mechanism belonged in the criminal case through motion practice, not in an original mandamus action against the warden.

C. Impact

1. Limits on using mandamus to litigate prison medical disagreements

The opinion functions as a clear signal that mandamus is not the proper tool to obtain a particular medication within a correctional treatment program when prison clinicians have offered an alternative MAT modality and the inmate’s dispute is essentially one of preference or medical judgment. Unless the relator can identify a legislatively created ministerial duty requiring the specific treatment, courts will not use mandamus to micromanage clinical decisions.

2. Reinforcement of “legislature creates mandamus duties” doctrine in the correctional context

By applying the “duty is the function of the legislature” line of cases to an inmate-treatment claim, the court strengthens an executive-branch defense in future mandamus actions: trial-court orders, generalized policy aspirations, or program availability will not substitute for a statutory, mandatory, and ministerial command directed to the respondent.

3. Emphasis on proper procedural vehicle: enforcement motion rather than original action

The adequate-remedy holding encourages litigants to use direct enforcement mechanisms in the originating case when the alleged violation is noncompliance with a trial-court entry. That approach also avoids turning the Supreme Court’s original jurisdiction into a forum for collateral disputes that can be resolved in trial courts through ordinary motion practice.

IV. Complex Concepts Simplified

  • Mandamus: a court order commanding a public official to perform a ministerial duty (one that is mandatory and leaves no discretion). It does not typically control discretionary judgments (like many medical determinations).
  • Clear legal right / clear legal duty: the relator must point to a definite legal entitlement and a matching mandatory obligation on the respondent—usually grounded in statute or binding law, not merely fairness or preference.
  • Adequate remedy in the ordinary course of law: if a normal legal process (appeal, motion to enforce, declaratory action, etc.) can address the problem, mandamus is generally unavailable.
  • MAT medications (antagonist vs. agonist):
    • Naltrexone (antagonist) blocks opioid receptors (like blocking a lock so a key cannot turn it).
    • Buprenorphine/methadone (agonists/partial agonists) activate opioid receptors in controlled ways to reduce cravings and withdrawal.
  • DRC protocols K-10 and K-12: internal clinical/administrative frameworks describing eligibility and procedures for different MAT tracks (K-10 for naltrexone; K-12/OTP for Suboxone or methadone). The court treated these protocols as governing how eligibility is determined within the program.
  • Civ.R. 11 signature requirement: a signature functions as certification that the filing is grounded in good faith; unsigned filings can be stricken, but courts may excuse oversights where no bad faith appears.

V. Conclusion

State ex rel. Sandy v. Spatny reinforces three practical rules for Ohio extraordinary-writ litigation in the prison-treatment setting: (1) mandamus requires a legislatively grounded, ministerial duty—trial-court entries and program participation do not automatically translate into a mandamus-enforceable obligation to provide a specific medication; (2) inmates cannot use mandamus to obtain a preferred MAT drug when clinicians have offered a different, clinically recommended MAT option under established protocols; and (3) when the dispute is framed as noncompliance with a trial-court entry, a motion to enforce that entry is an adequate remedy that bars mandamus.